AMBEV S.A. current report, Q4 FY2018

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. reports on specific securities and derivatives transactions occurring in November 2018, filed on December 10, 2018. The report is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002. The filing details treasury share movements, ADR conversions, and total return swap activities.

Key Financial Metrics and Transactions

The filing does not provide consolidated revenue, profit, cash flow, or margin data. It focuses exclusively on the following transaction volumes and values:

  • Treasury Shares (Common):
    • Initial Balance: 1,929,113 shares (0.0123% of total).
    • Final Balance: 1,882,713 shares (0.0120% of total).
    • Net Change: Decrease of 46,400 shares.
  • Option Exercises and Sales:
    • 111,475 shares sold via option exercise at R$ 9.3596 per share.
    • Total Volume: R$ 1,043,361.41.
  • Share Acquisition Plan:
    • 111,475 shares purchased at R$ 16.46 per share.
    • Total Volume: R$ 1,834,878.50.
  • Total Return Swaps (Ambev Luxembourg S.à.r.l.):
    • Total Quantity: 512,500 shares referenced.
    • Total Volume: R$ 8,488,220.00.
    • Transactions concluded on November 5 and November 6.

Material Changes

The filing does not provide comparative data against a prior period to assess material changes in financial performance. The primary change reported is the reduction in the company's treasury share balance from 1,929,113 to 1,882,713 shares, driven by the conversion of 46,400 shares into ADRs and the net effect of option exercises and share plan acquisitions.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook for future periods. It does not disclose specific risks or contingencies beyond the standard regulatory compliance statements regarding the reporting of securities and derivatives operations.

Investor Verification Checklist

  • Verify the impact of the 46,400 share conversion into ADRs on the total outstanding share count.
  • Confirm the pricing discrepancy between the option exercise price (R$ 9.3596) and the share acquisition plan price (R$ 16.46).
  • Review the economic exposure details of the R$ 8.49 million total return swap concluded by the Luxembourg subsidiary.
  • Note that this filing does not contain full-year 2018 financial results; refer to the Form 20-F for comprehensive financial statements.